Literature DB >> 24019729

Distribution of arylamine N-acetyltransferase 2 (nat2) genotypes among Omanis.

Musbah O M Tanira1, Mehmet Simsek, Khalid Al Balushi, Khulood Al Lawatia, Hameedah Al Barawani, Riad A Bayoumi.   

Abstract

OBJECTIVE: to determine the genotypes of arylamine N-acetyltransferase (NAT2) among 127 unrelated apparently healthy Omanis.
METHOD: Identify the most common known polymorphisms of NAT*2 gene namely, G(191)A, C(282)T, C(341)T, C(481)T, G(590)A, A(803)G and G(857)A using PCR-RFLP analysis.
RESULTS: Eleven allele variants (3 alternative) and 30 different genotypes were determined. The commonest alleles were found to be NAT*5B, NAT2*6A and NAT*4 with corresponding frequencies of 0.362, 0.248 and 0.189 respectively. The overall frequency of rapid acetylator alleles was 0.25.
CONCLUSION: A new allele variant containing G(590)A, C(282)T and T(341)C polymorphisms was found in one subject (was named NAT2*5J). The commonest genotypes were found to be 5B/5B, 5B/6A, 4/5B, 4/6A with frequencies 0.165, 0.157, 0.118, 0.110 and 0.079 respectively.

Entities:  

Keywords:  N-acetyltransferase (NAT2); Omani; genotyping

Year:  2003        PMID: 24019729      PMCID: PMC3174728     

Source DB:  PubMed          Journal:  J Sci Res Med Sci        ISSN: 1029-4066


  19 in total

Review 1.  Functional consequences of polymorphism of xenobiotic metabolising enzymes.

Authors:  M Ingelman-Sundberg
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

2.  Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.

Authors:  N M Woolhouse; M M Qureshi; S M Bastaki; M Patel; Y Abdulrazzaq; R A Bayoumi
Journal:  Pharmacogenetics       Date:  1997-02

3.  Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population.

Authors:  H R Dhaini; G N Levy
Journal:  Pharmacogenetics       Date:  2000-02

4.  Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.

Authors:  I Cascorbi; N Drakoulis; J Brockmöller; A Maurer; K Sperling; I Roots
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

5.  Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.

Authors:  R A McLellan; M Oscarson; J Seidegård; D A Evans; M Ingelman-Sundberg
Journal:  Pharmacogenetics       Date:  1997-06

Review 6.  N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

7.  Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.

Authors:  W A Anwar; S Z Abdel-Rahman; R A El-Zein; H M Mostafa; W W Au
Journal:  Carcinogenesis       Date:  1996-09       Impact factor: 4.944

8.  The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.

Authors:  S B Liggett; L E Wagoner; L L Craft; R W Hornung; B D Hoit; T C McIntosh; R A Walsh
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 9.  Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.

Authors:  David W Hein
Journal:  Mutat Res       Date:  2002-09-30       Impact factor: 2.433

Review 10.  Nomenclature for N-acetyltransferases.

Authors:  K P Vatsis; W W Weber; D A Bell; J M Dupret; D A Evans; D M Grant; D W Hein; H J Lin; U A Meyer; M V Relling
Journal:  Pharmacogenetics       Date:  1995-02
View more
  6 in total

1.  Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.

Authors:  N Ben Fredj; R Gam; E Kerkni; A Chaabane; Z Chadly; N Boughattas; K Aouam
Journal:  Pharmacogenomics J       Date:  2016-04-19       Impact factor: 3.550

2.  Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.

Authors:  Rika Yuliwulandari; Qomariyah Sachrowardi; Nao Nishida; Miwa Takasu; Lilian Batubara; Tri Panjiasih Susmiarsih; Jecti Teguh Rochani; Riyani Wikaningrum; Risa Miyashita; Taku Miyagawa; Abdul Salam Mudzakir Sofro; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

3.  NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations.

Authors:  Mansour S Al-Moundhri; Mohamed Al-Kindi; Maryam Al-Nabhani; Bassim Al-Bahrani; Ikram A Burney; Ali Al-Madhani; Shyam S Ganguly; Misbah Tanira
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

4.  Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer.

Authors:  Amjad Mahasneh; Amal Jubaili; Ahmed El Bateiha; Mohammad Al-Ghazo; Ismail Matalka; Mousa Malkawi
Journal:  Genet Mol Biol       Date:  2012-11-09       Impact factor: 1.771

5.  Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.

Authors:  Soukaina Guaoua; Ilham Ratbi; Fatima Zahra Laarabi; Siham Chafai Elalaoui; Imane Cherkaoui Jaouad; Amina Barkat; Abdelaziz Sefiani
Journal:  BMC Genet       Date:  2014-12-29       Impact factor: 2.797

6.  Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population

Authors:  Rami Nasr; Sally Temraz; Deborah Mukherji; Ali Shamseddine; Reem Akika; Sehrish Abbasi; Raja Khauli; Muhammad Bulbul; Hani Tamim; Nathalie K Zgheib
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.